LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 338

Search options

  1. Article ; Online: COVID-19 monitoring of school personnel through molecular salivary test and dried blood spot analysis.

    Henin, Dolaji / Fappani, Clara / Carmagnola, Daniela / Gori, Maria / Pellegrini, Gaia / Colzani, Daniela / Amendola, Antonella / Perrotta, Mariachiara / Tanzi, Elisabetta / Dellavia, Claudia

    Journal of global health

    2024  Volume 14, Page(s) 5004

    Abstract: Background: When the coronavirus disease 2019 (COVID-19) pandemic broke out, most countries enforced school closures as a precautionary measure. Although COVID-19 is still present three years later, schools have been reopened. We aimed to test the ... ...

    Abstract Background: When the coronavirus disease 2019 (COVID-19) pandemic broke out, most countries enforced school closures as a precautionary measure. Although COVID-19 is still present three years later, schools have been reopened. We aimed to test the association of molecular salivary testing (MST) and dried blood spot (DBS) analysis for community surveillance by investigating the immunological profile of a group of school staff during and following COVID-19 vaccination.
    Methods: We conducted the study in a school in Milan from April 2021, when school staff were administered the first dose of vaccine against SARS-CoV-2, until the school year ended in June 2022. Each participant provided samples for MST and DBS one month (T1, W1) after receiving their first dose of vaccine. Subsequently, they collected weekly MST samples for five weeks (W2-W6), plus a DBS sample in the last week (T2). Both samples were collected one (T3), four (T4), and seven months (T5) after the administration of the second vaccine dose in May 2021. A final DBS sample was collected one year (T6) after T3.
    Results: Sixty participants provided 327 MSTs and 251 DBSs. None of the MST samples tested positive for SARS-CoV-2 RNA during the study period. A total of 201 DBS samples tested positive for the IgG semiquantitative analysis. Negative samples were found only at T1 (20.45%) and T2 (7.32%). We observed borderline results at T1 (4.55%), T2 (7.32%), and T4 (2.70%). The anti-SARS-CoV-2 average antibody ratio increased after the second dose between T2 and T3, and the trend peaked after the third dose between T4 and T6. We performed an immunoenzymatic assay of antibodies against nucleocapsid protein on samples collected at T1 from five participants who reported having been infected before the study and from four subjects with an abnormal increase in the antibody values at T4. Two samples tested positive in the first group and two in the second one.
    Conclusions: Our findings show that MST and DBS could be effective tools in the active surveillance of school personnel and that schools could be considered safe settings in view of SARS-CoV-2 infection. Vaccines might have contributed to case and/or symptom reduction.
    MeSH term(s) Humans ; COVID-19 Vaccines ; Dried Blood Spot Testing ; RNA, Viral ; COVID-19/diagnosis ; SARS-CoV-2 ; Schools ; Antibodies, Viral
    Chemical Substances COVID-19 Vaccines ; RNA, Viral ; Antibodies, Viral
    Language English
    Publishing date 2024-02-09
    Publishing country Scotland
    Document type Journal Article
    ZDB-ID 2741629-X
    ISSN 2047-2986 ; 2047-2986
    ISSN (online) 2047-2986
    ISSN 2047-2986
    DOI 10.7189/jogh.14.05004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Increased reports of measles in the Metropolitan City of Milan, northern Italy, September 2023 to March 2024.

    Gori, Maria / Fappani, Clara / Bianchi, Silvia / Senatore, Sabrina / Colzani, Daniela / Pasutto, Priscilla / Baggieri, Melissa / Gioacchini, Silvia / Marchi, Antonella / Bucci, Paola / D'Ugo, Emilio / Faccini, Marino / Cereda, Danilo / Vezzosi, Luigi / Tanzi, Elisabetta / Magurano, Fabio / Amendola, Antonella

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

    2024  Volume 29, Issue 16

    Abstract: Since late 2023, the Metropolitan City of Milan and surrounding areas (northern Italy) have been experiencing a resurgence of measles, with most cases detected starting from January 2024. During this brief period, we observed measles in travellers from ... ...

    Abstract Since late 2023, the Metropolitan City of Milan and surrounding areas (northern Italy) have been experiencing a resurgence of measles, with most cases detected starting from January 2024. During this brief period, we observed measles in travellers from endemic areas, participants in international events, vaccinees and healthcare workers. Indigenous cases have also been identified. Even though we have not yet identified large and disruptive outbreaks, strengthening surveillance and vaccination activities is pivotal to help limit the impact of measles spread.
    MeSH term(s) Humans ; Measles virus/genetics ; Measles/epidemiology ; Measles/prevention & control ; Disease Outbreaks ; Vaccination ; Italy/epidemiology ; Measles Vaccine
    Chemical Substances Measles Vaccine
    Language English
    Publishing date 2024-04-19
    Publishing country Sweden
    Document type Journal Article
    ZDB-ID 1338803-4
    ISSN 1560-7917 ; 1025-496X
    ISSN (online) 1560-7917
    ISSN 1025-496X
    DOI 10.2807/1560-7917.ES.2024.29.16.2400201
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Letter to the editor: Further identification of a measles variant displaying mutations impacting molecular diagnostics, Northern Italy, 2024.

    Fappani, Clara / Gori, Maria / Bianchi, Silvia / Canuti, Marta / Colzani, Daniela / Baggieri, Melissa / Gioacchini, Silvia / D'Ugo, Emilio / Tanzi, Elisabetta / Magurano, Fabio / Amendola, Antonella

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

    2024  Volume 29, Issue 7

    MeSH term(s) Humans ; Pathology, Molecular ; Measles/diagnosis ; Measles/epidemiology ; Measles/genetics ; Measles virus/genetics ; Mutation ; Italy/epidemiology ; Disease Outbreaks ; Measles Vaccine
    Chemical Substances Measles Vaccine
    Language English
    Publishing date 2024-02-01
    Publishing country Sweden
    Document type Journal Article
    ZDB-ID 1338803-4
    ISSN 1560-7917 ; 1025-496X
    ISSN (online) 1560-7917
    ISSN 1025-496X
    DOI 10.2807/1560-7917.ES.2023.29.7.2400079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A large A(H3N2) influenza outbreak with a high attack rate in a drug user community in Italy, April 2022.

    Gori, Maria / Fappani, Clara / Bianchi, Silvia / Canuti, Marta / Colzani, Daniela / Ottogalli, Paolo / Duehren, Sarah / Tanzi, Elisabetta / Amendola, Antonella / Boschini, Antonio

    Epidemiology and infection

    2023  Volume 151, Page(s) e36

    Abstract: Despite the COVID-19 pandemic, influenza remains an important issue. Especially in community settings, influenza outbreaks can be difficult to control and can result in high attack rates. In April 2022, a large A(H3N2) influenza outbreak spread in the ... ...

    Abstract Despite the COVID-19 pandemic, influenza remains an important issue. Especially in community settings, influenza outbreaks can be difficult to control and can result in high attack rates. In April 2022, a large A(H3N2) influenza outbreak spread in the largest Italian drug-rehabilitation community. One hundred eighty-four individuals presented influenza-like symptoms (attack rate of 26.2%); 56% previously received the influenza vaccine. Sequence analyses highlighted a genetic drift from the vaccine strain, which may have caused the observed lack of protection.
    MeSH term(s) Humans ; Influenza, Human/epidemiology ; Influenza Vaccines ; Influenza A Virus, H3N2 Subtype ; Incidence ; Drug Users ; Pandemics ; COVID-19/epidemiology ; Disease Outbreaks ; Italy
    Chemical Substances Influenza Vaccines
    Language English
    Publishing date 2023-01-19
    Publishing country England
    Document type Journal Article
    ZDB-ID 632982-2
    ISSN 1469-4409 ; 0950-2688
    ISSN (online) 1469-4409
    ISSN 0950-2688
    DOI 10.1017/S0950268823000055
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Immunophenotypes of Newborns From SARS-CoV-2-infected Mothers.

    Stracuzzi, Marta / Paradiso, Laura / Panelli, Simona / Amendola, Antonella / Tanzi, Elisabetta / Fappani, Clara / Zuccotti, Gianvincenzo / Giacomet, Vania

    The Pediatric infectious disease journal

    2023  Volume 43, Issue 5, Page(s) e164–e168

    Abstract: Background: Little is known about the neonatal immunologic response to a maternal SARS-CoV-2 infection present during childbirth. Here we analyze a cohort of 75 neonates from SARS-CoV-2-infected mothers.: Methods: The SARS-CoV-2 infection status was ... ...

    Abstract Background: Little is known about the neonatal immunologic response to a maternal SARS-CoV-2 infection present during childbirth. Here we analyze a cohort of 75 neonates from SARS-CoV-2-infected mothers.
    Methods: The SARS-CoV-2 infection status was laboratory assessed by real-time reverse transcription polymerase chain reaction on nasopharyngeal swabs (NPS) in both mothers during childbirth and neonates within 24 hours of life. Immunophenotypes of peripheral blood mononucleated cells and SARS-CoV-2 antispike IgA, IgM and IgG of the newborns were recorded. Ten (13.3%) of 75 neonates had positive NPS for SARS-CoV-2; 17 of 75 (23%) were SARS-CoV-2-IgG seropositive, of which one with positive NPS. All the newborns resulted seronegative for SARS-CoV-2 IgA and IgM and were asymptomatic. Our cohort of newborns was divided into groups according to IgG seropositivity (IgG+/-) and NPS results (NPS+/-).
    Results: The count and proportion of lymphocyte subsets (evaluated measuring CD3, CD4, CD8 and CD19 markers) and of natural killer cells (evaluated by measuring the CD3-/CD16+/CD56+ subset) were all in the normal range, with no statistical differences among groups. We found a significant expansion of the T cell (CD3+) subset in the IgG+ group interpreted as the result of immune effects triggered by trained immunity in these newborns, but a decrease in CD4+ T cells for NPS+ neonates. It is therefore difficult to conclude that the decrease in CD4 can certainly be caused by an infection.
    Conclusions: A maternal SARS-CoV-2 infection resulted in an expansive effect of CD3+ T cells in IgG+ newborns; nonetheless, it seems not to affect structural and functional development of the newborn immune system.
    MeSH term(s) Female ; Humans ; Infant, Newborn ; SARS-CoV-2 ; COVID-19 ; Mothers ; Immunoglobulin G ; Immunoglobulin M ; Immunoglobulin A
    Chemical Substances Immunoglobulin G ; Immunoglobulin M ; Immunoglobulin A
    Language English
    Publishing date 2023-12-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000004289
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.

    Tanzi, Elisabetta / Bianchi, Silvia / Fappani, Clara / Gori, Maria / Colzani, Daniela / Passera, Ilaria / Tincati, Camilla / Canuti, Marta / Raviglione, Mario / Amendola, Antonella

    Journal of medical virology

    2023  Volume 95, Issue 5, Page(s) e28802

    Abstract: The majority of cervical cancer cases and associated deaths occur in low- and middle-income countries (LMICs), where sociocultural barriers, poor access to prevention and care, and technical and practical difficulties hinder screening coverage ... ...

    Abstract The majority of cervical cancer cases and associated deaths occur in low- and middle-income countries (LMICs), where sociocultural barriers, poor access to prevention and care, and technical and practical difficulties hinder screening coverage improvement. Using urine specimens for human papillomaviruses (HPV) molecular screening through automated testing platforms can help to overcome these problems. We evaluated the high-risk (HR) HPV detection performance of the Xpert® HPV test on GeneXpert® System (Cepheid), on fresh and dried urine (Dried Urine Spot [DUS]) samples as compared to an in-house polymerase chain reaction (PCR) genotyping assay. Forty-five concentrated urine samples collected from women with known cytological and HPV infection status, determined through in-house PCR and genotyping assays, were tested "as is" and as DUS with the Xpert® HPV test. This system detected HR-HPV in 86.4% of fresh and in 77.3% of dried urine samples collected from HPV+ women, correctly identifying HR-HPV infection in 100% of women with low- and high-grade lesions. High concordance (91.4%, k = 0.82) was found between PCR test and Xpert® HPV Test from urine. Urine-based Xpert® HPV test seems to be a suitable screening test for detection of HR-HPV infections associated with low- and high-grade lesions requiring follow-up monitoring or treatment. This methodology, relying on noninvasively collected samples and on available rapid testing platforms, could facilitate large, at-scale screening programs, particularly in LMICs and rural areas, thus reducing adverse outcomes of HPV infection and facilitating achievement of the WHO cervical cancer elimination goal.
    MeSH term(s) Female ; Humans ; Uterine Cervical Neoplasms/diagnosis ; Human Papillomavirus Viruses ; Papillomavirus Infections/diagnosis ; Developing Countries ; Early Detection of Cancer/methods ; Papillomaviridae/genetics ; Mass Screening/methods ; DNA, Viral/analysis
    Chemical Substances DNA, Viral
    Language English
    Publishing date 2023-05-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.28802
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities.

    Fappani, Clara / Gori, Maria / Bianchi, Silvia / Terraneo, Mara / Bilardi, Erica / Colzani, Daniela / Tanzi, Elisabetta / Canuti, Marta / Amendola, Antonella

    Journal of medical virology

    2023  Volume 95, Issue 10, Page(s) e29141

    Abstract: In the quest to eliminate measles virus (MV) and rubella virus (Ruv), every suspected case must be properly identified and diagnosed. Since 2017, in Milan (Italy), a total of 978 measles and rubella suspected cases (fever and rash) were investigated and ... ...

    Abstract In the quest to eliminate measles virus (MV) and rubella virus (Ruv), every suspected case must be properly identified and diagnosed. Since 2017, in Milan (Italy), a total of 978 measles and rubella suspected cases (fever and rash) were investigated and 310 were not laboratory confirmed (discarded cases). To improve surveillance activities, we investigated the presence in discarded cases of 8 other viral pathogens commonly associated with rash: human herpesvirus 6 (HHV-6) and 7 (HHV-7), parvovirus B19 (B19V), enterovirus (EV), Epstein-Barr virus (EBV), human adenovirus (HAdV), cytomegalovirus (HCMV), and SARS-CoV-2. Differential diagnosis was carried out on 289 discarded cases by multiplex real-time PCR assays. At least one pathogen was detected in 188 cases (65.1%) with HHV-7 being the most frequently detected virus. No difference in the number of detected infections overtime was observed and infections were identified in all age groups. As expected, most HHV-6, EV, HAdV, and HCMV-positive cases were found in children aged 0-4 years and HHV-7 was most frequent in the 15-39 age group. In light of the World Health Organization measles elimination goal, the introduction of laboratory methods for differential diagnosis is required for the final classification of clinically compatible cases. The used screening panel allowed us to increase the percentage of virus-positive cases to 87.5%, allowing us to clarify viral involvement and epidemiology, improve diagnosis, and strengthen surveillance activities. As all investigated pathogens were detected, this diagnostic panel was a suitable tool to complement MV and RuV surveillance activities.
    MeSH term(s) Child ; Humans ; Adolescent ; Young Adult ; Adult ; Diagnosis, Differential ; Epstein-Barr Virus Infections/diagnosis ; Antibodies, Viral ; Immunoglobulin M ; Herpesvirus 4, Human ; Measles/diagnosis ; Measles/epidemiology ; Measles/prevention & control ; Rubella/diagnosis ; Rubella/epidemiology ; Measles virus/genetics ; Enterovirus ; Exanthema ; Fever ; Enterovirus Infections/diagnosis ; Herpesvirus 6, Human/genetics ; Adenoviruses, Human
    Chemical Substances Antibodies, Viral ; Immunoglobulin M
    Language English
    Publishing date 2023-11-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.29141
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.

    Vanetti, Claudia / Stracuzzi, Marta / Crivellaro, Elisa / Ciciliano, Federica / Garziano, Micaela / Fenizia, Claudio / Biasin, Mara / Rubinacci, Valeria / Amendola, Antonella / Tanzi, Elisabetta / Zuccotti, Gian Vincenzo / Clerici, Mario / Giacomet, Vania / Trabattoni, Daria

    Frontiers in immunology

    2024  Volume 14, Page(s) 1301766

    Abstract: Background: Data on the efficacy of three SARS-CoV-2 mRNA BNT162b2 vaccine doses and the role of previous SARS-CoV-2-infection in enhancing vaccine immunogenicity in HIV-vertically-infected people living with HIV (PLWH) are limited, as is the duration ... ...

    Abstract Background: Data on the efficacy of three SARS-CoV-2 mRNA BNT162b2 vaccine doses and the role of previous SARS-CoV-2-infection in enhancing vaccine immunogenicity in HIV-vertically-infected people living with HIV (PLWH) are limited, as is the duration of vaccine-induced responses.
    Methods: SARS-CoV-2 plasma neutralizing activity (NA) against the European (B.1), Delta (B.1.617.2) and Omicron (B.1.1.529) variants and cell-mediated immunity (CMI) were analyzed in 29 ART-treated young PLWH (mean age 27.9 years) and 30 healthy controls (HC) who received three BNT162b2 vaccine doses. Individuals were stratified based on the presence/absence of previous SARS-CoV-2 infection (infected and vaccinated -SIV-; uninfected and vaccinated -SV-). Analyses were performed before vaccination (T0), 25 days from the second dose (T1), the day the third dose was administered (T2), and 3 months after the third dose (T3).
    Results: In PLWH: i) NA against all variants was higher in SIV compared to SV at T2 and was increased at T3; ii) switched-memory plasmablasts were augmented in SIV alone at T2 and T3; iii) a SARS-CoV-2 specific T cell memory was generated; iv) IFN-γ-secreting CD4+ and CD8+ T lymphocytes were boosted at T3 mainly in SV. CMI magnitude was reduced in PLWH compared to HC. Notably, after the third dose of vaccine viremia was unmodified, but CD4 T cell counts were reduced>20% in 3/29 PHLW.
    Conclusion: A third dose of BNT162b2 vaccine induces strong humoral and CMI responses in young ART-treated PLWH independently from a previous SARS-CoV-2 natural infection. The lower magnitude of CMI responses should be considered when planning mRNA vaccine booster doses in PLWH.
    MeSH term(s) Humans ; Adult ; COVID-19 Vaccines ; BNT162 Vaccine ; COVID-19/prevention & control ; SARS-CoV-2 ; Immunity, Cellular ; RNA, Messenger ; HIV Infections
    Chemical Substances COVID-19 Vaccines ; BNT162 Vaccine ; RNA, Messenger
    Language English
    Publishing date 2024-01-04
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1301766
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: [No title information]

    Tanzi, Elisabetta / Genovese, Camilla / Tettamanzi, Matilde / Fappani, Clara / Raviglione, Mario Carlo / Amendola, Antonella

    Journal of preventive medicine and hygiene

    2021  Volume 62, Issue 1 Suppl 3, Page(s) E18–E29

    Title translation COVID-19 vaccines: evidence, challenges and the future.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines ; Forecasting ; Humans ; SARS-CoV-2
    Chemical Substances COVID-19 Vaccines
    Language Italian
    Publishing date 2021-06-05
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 1102926-2
    ISSN 2421-4248 ; 1121-2233
    ISSN (online) 2421-4248
    ISSN 1121-2233
    DOI 10.15167/2421-4248/jpmh2021.62.1S3.2084
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: SARS-CoV-2 Seroprevalence Among School-Age Children in Milan: How Has It Changed With the Fourth Pandemic Wave?

    Mari, Alessandra / Garancini, Nicolò / Barcellini, Lucia / Zuccotti, Gian Vincenzo / Alberti, Luisella / Gaia, Paola / Amendola, Antonella

    The Pediatric infectious disease journal

    2022  Volume 41, Issue 8, Page(s) e344–e345

    MeSH term(s) Antibodies, Viral ; COVID-19/epidemiology ; Child ; Humans ; Pandemics ; SARS-CoV-2 ; Seroepidemiologic Studies
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2022-07-13
    Publishing country United States
    Document type Letter
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000003583
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top